The impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone
HomePublicationsThe impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone
The impact of treatment duration on relapse rates and health care costs among medicaid patients with opioid dependence treated with buprenorphine/naloxone
2014 Value in health
Kharitonova, E. | Zah, V. | Clay, E. | Ruby, J. | Aballea, S. | Toumi, M. |
Volume: 17,
Issue: 3,
Pages: A215-A216,
Health Care Costs, opioid dependence,
Buprenorphine/naloxone (BUP/NAL) combination is a treatment for the opioid dependence. Earlier studies showed that some patients, here, alternated between periods on and off treatment. The aim of this study was to compare health care resource utilization and costs between these patients and patients treated continuously.
